Synthace raised $35 million in Series C funding from Horizons Ventures and Sofinnova Partners
15 November 2021
15 November 2021
Total investments received (USD): 70.31M
Round value (USD): 35M
Round investors: Sofinnova PartnersHorizons Ventures
Company: Synthace
Related deals
Mestag Therapeutics raised $40 million in a round led by investors including SV Health Investors, Johnson & Johnson Innovation and Forbion.
Investments
02 March 2026
Anterior raised a $40 million series B funding round co-led by NEA and Sequoia Capital, alongside new investors FPV and Kinnevik.
Investments
01 February 2026
Trybe in the UK to raise $30M in an equity deal backed by Five Elms Capital in the USA
Investments
02 January 2026
Boltz secured $28 million in a seed funding round led by Zetta, Amplify and a16z, joined by Factorial Capital, Obvious Ventures and angel investors
Investments
30 December 2025
Engitix raised $25m in a Series A extension from Netherton Investments
Investments
09 December 2025
Belgium
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain